{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001001316","name":"TG THERAPEUTICS, INC.","summary":"TG Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. Its lead approved product is BRIUMVI (ublituximab-xiiy) 150 mg/6 mL Injection for intravenous therapy, indicated for relapsing forms of multiple sclerosis (RMS) in the United States. The company also has additional product candidates in clinical development and relies on third-party manufacturers and licensors for its pipeline.","people":[],"products":[{"name":"BRIUMVI (ublituximab-xiiy)","type":"service","description":"FDA-approved 150 mg/6 mL intravenous injection for treatment of relapsing forms of multiple sclerosis (RMS) in the United States."}],"partnerships":[{"partner_name":"Third-party licensors","partnership_type":"licensing","description":"BRIUMVI and other product candidates are in-licensed from third parties; disputes or non-performance could adversely affect development and commercialization.","start_date":null},{"partner_name":"Collaboration and commercialization partners","partnership_type":"strategic","description":"Company relies on collaboration and commercialization partners to develop, fund, manufacture, and commercialize drug products and product candidates.","start_date":null},{"partner_name":"Third-party manufacturers","partnership_type":"development","description":"Contracts with third parties for manufacture and testing of BRIUMVI for commercial supply and all clinical product supply.","start_date":null}],"affiliations":[],"origin":{"leaf":"5705c93e7795266292070678bcd21e1d48d9c86f19a479f14895586c8860941e","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"64f68dcff7d5c22fb312a5dfc8c157de9c93849cac32d02b4e31f358a0d6c2e6","parent":"f5290167761621ab7e9f3164d179066ec21d039e770cc2fdf6cd8c4341965a54","source":"0001437749-26-006133","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":113,"hourly_limit":500,"remaining":387,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}